Form 8-K - Current report:
SEC Accession No. 0001906324-25-000037
Filing Date
2025-03-04
Accepted
2025-03-04 16:15:31
Documents
15
Period of Report
2025-02-28
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qdel-20250228.htm   iXBRL 8-K 34766
2 EX-16.1 qdel030420258-kex161.htm EX-16.1 2935
  Complete submission text file 0001906324-25-000037.txt   191956

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20250228.xsd EX-101.SCH 2145
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20250228_def.xml EX-101.DEF 14443
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20250228_lab.xml EX-101.LAB 25398
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20250228_pre.xml EX-101.PRE 15018
17 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20250228_htm.xml XML 2704
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-41409 | Film No.: 25704613
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)